149 related articles for article (PubMed ID: 37989800)
1. Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP-HF II trial.
Litwin SE; Komtebedde J; Seidler T; Borlaug BA; Winkler S; Solomon SD; Eicher JC; Mazimba S; Khawash R; Sverdlov AL; Hummel SL; Bugger H; Boenner F; Hoendermis E; Cikes M; Demers C; Silva G; van Empel V; Starling RC; Penicka M; Cutlip DE; Leon MB; Kitzman DW; van Veldhuisen DJ; Shah SJ;
Eur J Heart Fail; 2024 Jan; 26(1):177-189. PubMed ID: 37989800
[TBL] [Abstract][Full Text] [Related]
2. Exercise-Induced Left Atrial Hypertension in Heart Failure With Preserved Ejection Fraction.
Litwin SE; Komtebedde J; Hu M; Burkhoff D; Hasenfuß G; Borlaug BA; Solomon SD; Zile MR; Mohan RC; Khawash R; Sverdlov AL; Fail P; Chung ES; Kaye DM; Blair J; Eicher JC; Hummel SL; Zirlik A; Westenfeld R; Hayward C; Gorter TM; Demers C; Shetty R; Lewis G; Starling RC; Patel S; Gupta DK; Morsli H; Penicka M; Cikes M; Gustafsson F; Silvestry FE; Rowin EJ; Cutlip DE; Leon MB; Kitzman DW; Kleber FX; Shah SJ;
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1103-1117. PubMed ID: 36939661
[TBL] [Abstract][Full Text] [Related]
3. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.
Shah SJ; Borlaug BA; Chung ES; Cutlip DE; Debonnaire P; Fail PS; Gao Q; Hasenfuß G; Kahwash R; Kaye DM; Litwin SE; Lurz P; Massaro JM; Mohan RC; Ricciardi MJ; Solomon SD; Sverdlov AL; Swarup V; van Veldhuisen DJ; Winkler S; Leon MB;
Lancet; 2022 Mar; 399(10330):1130-1140. PubMed ID: 35120593
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
5. Rationale and Design of the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (Reduce LAP-HF) Trial.
Hasenfuss G; Gustafsson F; Kaye D; Shah SJ; Burkhoff D; Reymond MC; Komtebedde J; Hünlich M;
J Card Fail; 2015 Jul; 21(7):594-600. PubMed ID: 26055211
[TBL] [Abstract][Full Text] [Related]
6. No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility Studies.
Udelson JE; Barker CM; Wilkins G; Wilkins B; Gooley R; Lockwood S; Potter BJ; Meduri CU; Fail PS; Solet DJ; Feldt K; Kriegel JM; Shaburishvili T
JACC Heart Fail; 2023 Aug; 11(8 Pt 2):1121-1130. PubMed ID: 37115132
[TBL] [Abstract][Full Text] [Related]
7. Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial.
Patel RB; Silvestry FE; Komtebedde J; Solomon SD; Hasenfuß G; Litwin SE; Borlaug BA; Price MJ; Kawash R; Hummel SL; Cutlip DE; Leon MB; van Veldhuisen DJ; Rieth AJ; McKenzie S; Bugger H; Mazurek JA; Kapadia SR; Vanderheyden M; Ky B; Shah SJ
JAMA Cardiol; 2024 Jun; 9(6):507-522. PubMed ID: 38630494
[TBL] [Abstract][Full Text] [Related]
8. One-Year Safety and Clinical Outcomes of a Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction in the Reduce Elevated Left Atrial Pressure in Patients With Heart Failure (REDUCE LAP-HF I) Trial: A Randomized Clinical Trial.
Shah SJ; Feldman T; Ricciardi MJ; Kahwash R; Lilly S; Litwin S; Nielsen CD; van der Harst P; Hoendermis E; Penicka M; Bartunek J; Fail PS; Kaye DM; Walton A; Petrie MC; Walker N; Basuray A; Yakubov S; Hummel SL; Chetcuti S; Forde-McLean R; Herrmann HC; Burkhoff D; Massaro JM; Cleland JGF; Mauri L
JAMA Cardiol; 2018 Oct; 3(10):968-977. PubMed ID: 30167646
[TBL] [Abstract][Full Text] [Related]
9. Post-exercise left atrial conduit strain predicted hemodynamic change in heart failure with preserved ejection fraction.
Cheng JF; Huang PS; Chen ZW; Huang CY; Lan CW; Chen SY; Lin LY; Wu CK
Eur Radiol; 2024 Mar; 34(3):1825-1835. PubMed ID: 37650970
[TBL] [Abstract][Full Text] [Related]
10. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
[TBL] [Abstract][Full Text] [Related]
11. Left atrial to coronary sinus shunting for treatment of heart failure with mildly reduced or preserved ejection fraction: The ALT FLOW Early Feasibility Study 1-year results.
Urey MA; Hibbert B; Jorde U; Eckman P; Simard T; Labinaz M; Nazer B; Wiley M; Gupta B; Sauer A; Shah H; Sorajja P; Pineda AM; Missov E; Mahmud E; Kahwash R; Lilly S; Latib A; Murthy S; Fam N; Garcia S; Chung ES; Klein L; Cheng R; Houston BA; Amoroso NS; Chang L; Gafoor S; Chaudhry SP; Hermiller J; Schwartz JG; Aldaia L; Koulogiannis K; Gray WA; Zahr F
Eur J Heart Fail; 2024 Apr; 26(4):1065-1077. PubMed ID: 38606485
[TBL] [Abstract][Full Text] [Related]
12. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
[TBL] [Abstract][Full Text] [Related]
13. Impaired left atrial strain predicts abnormal exercise haemodynamics in heart failure with preserved ejection fraction.
Telles F; Nanayakkara S; Evans S; Patel HC; Mariani JA; Vizi D; William J; Marwick TH; Kaye DM
Eur J Heart Fail; 2019 Apr; 21(4):495-505. PubMed ID: 30652393
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II).
Berry N; Mauri L; Feldman T; Komtebedde J; van Veldhuisen DJ; Solomon SD; Massaro JM; Shah SJ
Am Heart J; 2020 Aug; 226():222-231. PubMed ID: 32629295
[TBL] [Abstract][Full Text] [Related]
15. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
[TBL] [Abstract][Full Text] [Related]
16. A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.
Hasenfuß G; Hayward C; Burkhoff D; Silvestry FE; McKenzie S; Gustafsson F; Malek F; Van der Heyden J; Lang I; Petrie MC; Cleland JG; Leon M; Kaye DM;
Lancet; 2016 Mar; 387(10025):1298-304. PubMed ID: 27025436
[TBL] [Abstract][Full Text] [Related]
17. Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality.
Verbrugge FH; Omote K; Reddy YNV; Sorimachi H; Obokata M; Borlaug BA
Eur Heart J; 2022 May; 43(20):1941-1951. PubMed ID: 35139159
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
[TBL] [Abstract][Full Text] [Related]
19. Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
Wolsk E; Kaye D; Komtebedde J; Shah SJ; Borlaug BA; Burkhoff D; Kitzman DW; Lam CSP; van Veldhuisen DJ; Ponikowski P; Petrie MC; Hassager C; Møller JE; Gustafsson F
JACC Heart Fail; 2019 Apr; 7(4):321-332. PubMed ID: 30852235
[TBL] [Abstract][Full Text] [Related]
20. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.
Fudim M; Fail PS; Litwin SE; Shaburishvili T; Goyal P; Hummel SL; Borlaug BA; Mohan RC; Patel RB; Mitter SS; Klein L; Rocha-Singh K; Patel MR; Reddy VY; Burkhoff D; Shah SJ
Eur J Heart Fail; 2022 Aug; 24(8):1410-1414. PubMed ID: 35598154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
